Lenox Wealth Advisors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$11K Buy
86
+45
+110% +$5.42K ﹤0.01% 475
2021
Q4
$5K Hold
41
﹤0.01% 614
2021
Q3
$6K Hold
41
﹤0.01% 538
2021
Q2
$6K Buy
+41
New +$6.64K ﹤0.01% 535
2020
Q3
Sell
-582
Closed -$67K 659
2020
Q2
$67K Hold
582
0.01% 131
2020
Q1
$57K Hold
582
0.01% 125
2019
Q4
$85K Hold
582
0.01% 126
2019
Q3
$78K Hold
582
0.01% 126
2019
Q2
$67K Buy
+582
New +$68.2K 0.01% 131
2016
Q4
Sell
-206
Closed -$26K 199
2016
Q3
$26K Hold
206
0.01% 124
2016
Q2
$24K Hold
206
0.01% 124
2016
Q1
$21K Hold
206
0.01% 131
2015
Q4
$21K Hold
206
0.01% 132
2015
Q3
$19K Buy
+206
New +$20.7K 0.01% 140
2015
Q2
Sell
-206
Closed -$24K 334
2015
Q1
$24K Hold
206
0.01% 114
2014
Q4
$23K Hold
206
0.01% 124
2014
Q3
$20K Hold
206
0.01% 127
2014
Q2
$21K Hold
206
0.01% 103
2014
Q1
$19K Sell
206
-103
-33% -$9.49K 0.01% 101
2013
Q4
$28K Buy
+309
New +$26.7K 0.02% 95

Other funds holding ZBH

Lenox Wealth Advisors's ZBH Position: Q1 2022 in Review

Lenox Wealth Advisors increased its Zimmer Biomet (ZBH) stake by 110% in Q1 2022, buying an estimated $5.42K and bringing the position to 86 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #475.

Lenox Wealth Advisors first reported a position in ZBH in Q4 2013 and has held it in 20 quarters since. The position peaked at $85K in Q4 2019. 978 funds tracked by Wall St. Rank hold ZBH as of Q1 2022.

  • Lenox Wealth Advisors held 86 shares of Zimmer Biomet worth $11K as of Q1 2022.
  • Lenox Wealth Advisors bought 45 Zimmer Biomet shares in Q1 2022, an estimated $5.42K.
  • Zimmer Biomet made up ﹤0.01% of Lenox Wealth Advisors's portfolio in Q1 2022, its #475 holding.
  • Lenox Wealth Advisors first reported a position in Zimmer Biomet in Q4 2013 and has held it in 20 quarters since.
  • Lenox Wealth Advisors's Zimmer Biomet position peaked at $85K in Q4 2019.
  • 978 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2022.

Based on Lenox Wealth Advisors's 13F filing for Q1 2022, filed 14 Apr 2022.